| Literature DB >> 33956052 |
Jacqueline J O N van den Bosch1,2, Vincenzo Pennisi1, Azzurra Invernizzi3,4, Kaweh Mansouri5,6, Robert N Weinreb7, Hagen Thieme1, Michael B Hoffmann1,8, Lars Choritz1.
Abstract
Purpose: To explore the effect of gaze direction and eyelid closure on intraocular pressure (IOP).Entities:
Year: 2021 PMID: 33956052 PMCID: PMC8107486 DOI: 10.1167/iovs.62.6.8
Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN: 0146-0404 Impact factor: 4.799
Patient Characteristics
| Characteristic | Study Eye (n = 11) | Fellow Eye (n = 11) |
|---|---|---|
| Age [years] | 72 ± 5 | |
| Gender | ||
| Male | 6 (55) | |
| Female | 5 (45) | |
| Glaucoma stage | ||
| Early | 8 (73) | 11 (100) |
| Moderate | 2 (18) | — |
| Severe | 1 (9) | — |
| Sensor in the right eye | 8 (73) | 3 (27) |
| BCVA (ETDRS letter score) | 83 [79, 86] | 82 ± 4 |
| MD [dB] | −3 [−6, −1] | −2 ± 2 |
| VFI [dB] | 95 [90, 99] | 97 [92,99] |
| PSD [dB] | 2.5 [1.5-6.5] | 2.0 [1.7-3.9] |
| CCT [µm] | 568 ± 49 | 566 ± 44 |
| Glaucoma surgeries | ||
| 0 | 9 (82) | 9 (82) |
| 1 | 1 (9) | 2 (18) |
| 2 | 1 (9) | — |
| Glaucoma medications | ||
| 0 | 4 (36) | 3 (27) |
| 1 | 1 (9) | 2 (18) |
| 2 | 3 (27) | 3 (27) |
| 3 | 3 (27) | 3 (27) |
Normal distributed continuous data presented as mean ± SD, non-normal distributed data presented as median [Interquartile range] and counts presented as number (%).
BCVA, best-corrected visual acuity (using ETDRS letters); MD, mean defect in visual field, VFI, Visual field Index (Humphrey Field Analyzer III); PSD, Visual field–Pattern Standard Deviation; CCT, Central Corneal Thickness.
One female patient of 77 years was staged with severe glaucoma in the study eye (BCVA= 58, MD=-21.46 and PSD = 13.23 dB, left eye). Two patients were staged with moderate glaucoma in the study eye, one male of 78 years (BCVA = 88, MD= -10.29, PSD =8.81, left eye) and one female of 76 years (BCVA = 86, MD = −6.98, PSD = 6.4, right eye). The other 8 patients were staged with mild glaucoma in the study eye.
One patient had previously undergone selective laser treatment in the study eye. Another patient had trabeculectomy and selective laser trabeculoplasty in the study eye. The filtering bleb in the latter patient was not functional (being flat and scarred), and pressure-lowering medication was necessary at the time.
IOP-Comparison for All Gaze Positions
| 10* IOP [mm Hg] | 20* IOP [mm Hg] | 25* IOP [mm Hg] | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gaze | Position | Baseline | Difference |
| Position | Baseline | Difference |
| Position | Baseline | Difference |
|
| S | 18.6 ± 1.26 | 17.5 ± 1.47 | 1.1 ± 0.61 | 0.110 | 20.8 ± 1.47 | 16.9 ± 1.35 | 3.9 ± 1.38 | 0.018 | 21.4 ± 1.53 | 16.9 ± 1.25 | 4.4 ± 1.48 | 0.014 |
| ST | 17.6 ± 1.33 | 16.7 ± 1.44 | 0.87 ± 0.28 | 0.011 | 19.2 ± 1.30 | 16.6 ± 1.30 | 2.6 ± 0.70 | 0.004 (0.008) | 20.1 ± 1.32 | 17.1 ± 1.25 | 2.9 ± 0.94 | 0.011 |
| T | 17.3 ± 1.39 | 16.7 ± 1.41 | 0.60 ± 0.083 | <0.001 (0.006) | 17.6 ± 1.39 | 16.5 ± 1.43 | 1.1 ± 0.36 | 0.012 | 18.1 ± 1.29 | 16.9 ± 1.32 | 1.2 ± 0.27 | 0.001 (0.007) |
| IT | 16.9 ± 1.45 | 16.5 ± 1.45 | 0.33 ± 0.14 | 0.039 | 16.8 ± 1.44 | 16.3 ± 1.44 | 0.47 ± 0.12 | 0.003 (0.007) | 16.9 ± 1.34 | 16.7 ± 1.31 | 0.14 ± 0.27 | 0.603 |
| I | 16.3 ± 1.56 | 16.6 ± 1.44 | −0.31 ± 0.17 | 0.098 | 15.8 ± 1.50 | 16.3 ± 1.45 | −0.45 ± 0.23 | 0.074 | 15.7 ± 1.43 | 16.3 ± 1.35 | −0.55 ± 0.31 | 0.110 |
| IN | 15.8 ± 1.45 | 16.5 ± 1.44 | −0.71 ± 0.16 | 0.001 (0.007) | 15.1 ± 1.46 | 16.2 ± 1.40 | −1.1 ± 0.18 | <0.001 (0.006) | 14.9 ± 1.36 | 16.5 ± 1.35 | −1.6 ± 0.23 | <0.001 (0.006) |
| N | 16.2 ± 1.42 | 16.4 ± 1.44 | −0.18 ± 0.17 | 0.309 | 15.5 ± 1.40 | 16.2 ± 1.40 | −0.71 ± 0.47 | 0.161 | 15.8 ± 1.44 | 16.4 ± 1.29 | −0.51 ± 0.67 | 0.420 |
| SN | 17.1 ± 1.36 | 16.4 ± 1.42 | 0.66 ± 0.42 | 0.143 | 17.9 ± 1.50 | 16.0 ± 1.39 | 1.9 ± 0.88 | 0.061 | 18.9 ± 1.63 | 16.2 ± 1.20 | 2.9 ± 1.40 | 0.083 |
| Overall | 17.0 ± 0.48 | 16.7 ± 0.49 | 0.29 ± 0.12 | 17.3 ± 0.52 | 16.4 ± 0.47 | 0.97 ± 0.29 | 17.7 ± 0.53 | 16.6 ± 0.44 | 1.1 ± 0.36 | |||
Normal distributed continuous data presented as mean ± SEM.
S, superior; ST, superior temporal; T, temporal; IT, inferior temporal; I; inferior; IN, inferior nasal; N, nasal; SN, superior nasal.
*Acquired IOP data during gaze experiments presented for each eccentricity separately (N = 11, mean over 3 repetitions).
IOP values shown (from left to right) for each gaze position, preceding primary gaze as baseline measurement, and the difference between each position and preceding baseline (ΔIOP).
A Bonferroni-Holm correction was applied for eight paired t-tests to reduce the alpha error and is depicted in brackets.
IOP values and differences (ΔIOP) were averaged over all gaze positions and baselines for each eccentricity separately (Overall row).
Figure 1.Example IOP recording and analysis during a gaze experiment. (A) IOP recording of one patient while alternating eccentric gaze positions with primary gazes at 25°. The scatter of data points in each position of about 2 mm Hg comprised IOP changes that coincided with heart-rate and are therefore related to the ocular pulse amplitude rather than noise. (B) Depiction of ocular pulse and IOP analysis. The ocular pulse is visible within IOP variability that occurs within several seconds (gray line). Change in mean IOP was calculated by subtracting mean IOP during each gaze direction from primary gaze. Hence, all IOP measurements refer back to the baseline, acting as an internal reference to reduce noise from various sources of variability on measurements. Negative and positive ΔIOP denote an IOP decrease and increase, respectively, for eccentric gaze compared to the primary position. In A, blue arrows indicate gaze directions and blue dots indicate primary gazes, all in 12 s intervals. In both A and B, yellow arrows indicate the 8 s analysis intervals. The two time windows ‘TWinitial’ and ‘TWfinal’ used for time course analysis of IOP included the initial and final 2 seconds of each eccentric gaze position analysis interval.
Figure 2.IOP time courses for two representative patients upon eyelid closure. (A) Patient with IOP drop immediately after an initial IOP peak. (B) Patient with delayed IOP drop after a moderate initial increase. Yellow errors indicate the analysis intervals for the quantitative assessment of eyelid closure depicted in Figure 4.
Figure 4.Comparison of mean ΔIOP in vertical gaze directions with eyelid closure. Mean ΔIOP ± SEM for upgaze (‘SNT’, i.e. superior nasal to superior temporal: average ΔIOP across directions SN, S and ST) at the three eccentricities, followed by downgazes or ‘INT’ (superior nasal to superior temporal), and lastly for eyelid closure. As a result, from left to right the position of the initially extracted eyelid moves further down for each condition. Data on gaze (n=11) and eyelid closure (n=9) are averages of 3 and 4 repetitions, respectively. For details on the analysis see Methods. One-sample T-tests were performed for each mean ΔIOP to test the difference to “0” on the group level. P-values (Bonferroni-Holm adjusted alpha level) from left to right: 25SNT: P = 0.02 (0.02), 20SNT: P= 0.02 (0.01), 10SNT: P = 0.08 (0.03), 10INT: P = 0.08 (0.05), 20INT: P = 0.02 (0.01), 25INT: P = 0.02 (0.008), eyelid closure: P <0.001 (0.007). Hence, the only significant P-value after correction was for eyelid closure and is indicated in the top figure. In addition, paired T-tests compared each gaze position on the vertical axis with eyelid closure (not shown). P-values (Bonferroni-Holm adjusted alpha level) from left to right: 25SNT, P = 0.002 (0.01), 20SNT P<0.001 (0.01), 10SNT P<0.001 (0.008), 10INT P=0.002 (0.02), 20INT P= 0.004 (0.03), 25INT P=0.01 (0.05). Individual plots (Mean ΔIOP ± SD) depict a similar trend in decreasing ΔIOP from upward to downward gaze and eyelid closure in most patients and the significances for eyelid closure vs. baseline as determined with paired t-tests (P< .05 = *, P≤ .01 = **, P≤ .001 = ***), as detailed in Supplemental Table S2.
Figure 3.Mean Δ IOP (n=11) for each gaze direction and eccentricity. Mean ΔIOP for each gaze direction and eccentricity at the group level (top left) and for each individual separately. Gaze directions in eight directions are presented as ‘S’ (Superior), ‘ST’ (Superior Temporal), ‘T’ (Temporal), ‘IT’ (Inferior Temporal), ‘I’ (Inferior). ‘IN’ (Inferior Nasal), ‘N’ (Nasal) and ‘SN’ (Superior Nasal). Magnitude of IOP-change scales with disc diameter. The discs in the individual plots are scaled down linearly from the size key with the size of the plots. For the group level statistics, asterisks indicate significance of paired T-tests corrected for multiple tests (P≤ .01 = **, P≤ .001 = ***). Marked IOP increase for upward gazes is visible especially for patients 1, 6, 7 and 9. Overall, most patients show similar trends of IOP increase or decrease in similar directions and eccentricities, for a detailed assessment see Supplemental Table S1.